Cargando…
S268: INTERIM ANALYSIS OF A PHASE 2 TRIAL TO ASSESS THE EFFICACY AND SAFETY OF CRIZANLIZUMAB IN SICKLE CELL DISEASE PATIENTS WITH PRIAPISM (SPARTAN)
Autores principales: | Anderson, Alan, El Rassi, Fuad, Debaun, Michael R., Idowu, Modupe, Kanter, Julie, Adam, Soheir, Curtis, Susanna, Liles, Darla, Andemariam, Biree, Mclemore, Morgan L., Sheppard Nickel, Robert, Ramadas, Poornima, Paulose, Jincy, Laine, Dram, Khan, Mahmudul, Darbari, Deepika, Burnett, Arthur L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428507/ http://dx.doi.org/10.1097/01.HS9.0000967984.54376.db |
Ejemplares similares
-
Successful Treatment of SCD-Related Priapism With Crizanlizumab: A Case Series
por: Idowu, Modupe, et al.
Publicado: (2023) -
Pharmacokinetics, pharmacodynamics, safety, and efficacy of crizanlizumab in patients with sickle cell disease
por: Kanter, Julie, et al.
Publicado: (2022) -
Burden of disease, treatment utilization, and the impact on education and employment in patients with sickle cell disease: A comparative analysis of high‐ and low‐ to middle‐income countries for the international Sickle Cell World Assessment Survey
por: Osunkwo, Ifeyinwa, et al.
Publicado: (2022) -
5610357 REDUCTION IN BLOOD TRANSFUSION BURDEN FOLLOWING INITIATION OF VOXELOTOR OR CRIZANLIZUMAB: A CASE SERIES
por: Baruwa Etti, A., et al.
Publicado: (2023) -
Phylarchus and the Spartan revolution
por: Africa, Thomas W.
Publicado: (1961)